CeGaT Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 168

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 2

CeGaT General Information

Description

Provider of diagnostic biotechnology services intended to offer gene analyses for a wide range of medical, research and pharmaceutical applications. The company provides DNA and RNA sequencing of humans, animals, plants, and microorganisms, and also offers genetic analysis to researchers and pharmaceutical companies for clinical trials and medical innovations, helping doctors and patients find the genetic causes of rare diseases.

Contact Information

Website
cegat.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Paul-Ehrlich-Strasse 23
  • 72076 Tubingen
  • Germany
+49 07071
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Paul-Ehrlich-Strasse 23
  • 72076 Tubingen
  • Germany
+49 07071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CeGaT Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CeGaT‘s full profile, request access.

Request a free trial

CeGaT Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of diagnostic biotechnology services intended to offer gene analyses for a wide range of medical, research and
Discovery Tools (Healthcare)
Tubingen, Germany
168 As of 2024

Cambridge, MA
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CeGaT Competitors (62)

One of CeGaT’s 62 competitors is Arbor Biotechnologies, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arbor Biotechnologies Venture Capital-Backed Cambridge, MA
Anaveon Venture Capital-Backed Basel, Switzerland
Agomab Therapeutics Formerly VC-backed Antwerp, Belgium
Verve Therapeutics Formerly VC-backed Boston, MA
Virometix Venture Capital-Backed Schlieren, Switzerland
You’re viewing 5 of 62 competitors. Get the full list »

CeGaT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CeGaT Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CeGaT‘s full profile, request access.

Request a free trial

CeGaT FAQs

  • When was CeGaT founded?

    CeGaT was founded in 2009.

  • Where is CeGaT headquartered?

    CeGaT is headquartered in Tubingen, Germany.

  • What is the size of CeGaT?

    CeGaT has 168 total employees.

  • What industry is CeGaT in?

    CeGaT’s primary industry is Discovery Tools (Healthcare).

  • Is CeGaT a private or public company?

    CeGaT is a Private company.

  • What is CeGaT’s current revenue?

    The current revenue for CeGaT is .

  • Who are CeGaT’s investors?

    B. Braun has invested in CeGaT.

  • Who are CeGaT’s competitors?

    Arbor Biotechnologies, Anaveon, Agomab Therapeutics, Verve Therapeutics, and Virometix are some of the 62 competitors of CeGaT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process